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Abstract 
   
This study aimed to explore the use of quarterly monitoring reports by STOP HIV/AIDS 
representatives from all Health Authorities in British Columbia. The STOP HIV/AIDS project is a 
provincial initiative that aims to reduce the burden of HIV/AIDS in British Columbia. The study 
deployed in-depth interviews with twelve key informants and a ten survey questionnaire to 
deepen our understanding of the usefulness and the role the quarterly monitoring reports play in 
informing program planning. The findings found reports to be useful to end-users and provide 
many benefits including evaluating progress, informing decision-making and a tool to compare 
work across Health Authorities. Findings also suggest changing the format of the reports, 
adding more indicators and providing a high level summary page of the report. Overall, 
informants found the report to be useful for monitoring progress, a tool to compare across 
Health Authorities and a rich source of data to refer to. 
 
 
 
 
 
 
 
 
 
Introduction 
 
Purpose of report 
This capstone project is a mixed method study exploring the role that STOP HIV/AIDS 
surveillance reports and their performance indicators play in informing policy decisions in British 
Columbia. This capstone aims to provide a deeper understanding of the significance of 
surveillance reports to Health Authority stakeholders and conclude with recommendations on 
how to improve the surveillance reports to better meet user needs. The report will begin with a 
literature review on the purpose, role and significance of public health surveillance systems in 
general and then put into context with HIV/AIDS and the STOP HIV/AIDS quarterly reports. The 
mixed methods used in this study and results of the study will also be discussed. Finally, the 
recommendations and the implications of this study along with future research goals will be 
addressed.  
Background on STOP HIV/AIDS project 
  
In 1981, the Center for Disease Control and Prevention first reported cases of AIDS in 
parts of the US (Morrison, 2001). 35 years later, 71 million people have been infected with HIV 
and approximately 34 million have died of HIV (UNAIDS, 2016). The pandemic has 
disproportionately affected different populations and regions globally. In North America the 
HIV/AIDs epidemic is more prevalent in injection drug users (IDU) and males who have sex with 
males (MSM) than the rest of the population. (Morrison, 2001).  
Like other countries, Canada and more specifically, British Columbia has been adversely 
affected by HIV/AIDS since the early 1980’s (Montaner, 2006). At the height of the epidemic in 
the 1990s, one British Columbia was dying a day from AIDS (McInnes, 2009). The first rise in 
HIV/AIDS cases occurred in mid-1980’s and largely affected the MSM community. Later in the 
mid 1990’s, there was a rapid increase in HIV cases affecting IDU and female sex trader 
workers (McInnes, 2009). In British Columbia, the majority of HIV/AIDS cases continue to arise 
through MSM and IDU transmission. Although similar patterns of the epidemic in IDU and MSM 
were observed in other large cities in Canada including Montreal and Toronto, Vancouver has 
the largest populations of high-risk individuals, injection drug users (McInnes, 2009). 
However, after the introduction of HAART treatment in 1996 AIDS related mortality was 
reduced by about 85% in a three year span (BC-CfE, 2014). As of 2015, British Columbia 
accounts for about 13% of new HIV cases in Canada and those numbers continue to decrease 
(Catie, 2015). BC has been able to reduce the spread of HIV, through the implementation of 
innovative prevention strategies and harm reduction initiatives (BC-CfE, 2014). Despite these 
advances, gaps along the continuum of HIV care remain; approximately a quarter of HIV-
positive individuals are unaware of the sero-status and less than half of all HIV-positive 
individuals in BC are receiving HAART treatment (Heath, 2014)   
Ever since the introduction of combination anti-retroviral treatment (also known as Highly 
Active Antiretoviral Therapy) in the 1990’s the treatment has been suspected to play a key role 
in prevention of HIV transmission. More specifically, after the introduction of highly active 
antiretroviral therapy (HAART) in 1996 there has been a substantial reduction in AIDS-related 
admission and morbidities globally (Montaner, 2006; Montaner, 2014). This paved the way for 
applying HAART treatment as prevention (TasP). TasP is a UNAIDS and World Health 
Organization endorsed concept that has the potential to significantly alter the epidemic 
worldwide. The concept stems from evidence that drug treatment lowers the amount of virus in 
the body – improving the health of those on the treatment, lowering the amount of virus in the 
community and preventing transmission of HIV infection through viral suppression (BCMOH, 
2012).  
Evidence on the effect of HAART on HIV transmission first arose from studies on vertical 
HIV transmission from mother-to-child (De Cock KM, 2000). Clinical trials have shown that 
reducing the mothers HIV concentrations in HIV transmission with HAART treatment decreases 
the HIV transmission to the child (De Cock KM, 2000). The expansion of HAART availability 
subsequently led to profound decreases in vertical HIV transmission (De Cock KM, 2000).  
Clinical trials in heterosexual couples also found similar results. A prospective study 
among 3381 serodiscordant heterosexual couples in 7 countries in Africa examining HAART 
use and HIV-1 transmission reported that ART use by the infected person was associated with a 
92% reduction in risk of HIV-1 transmission to their partner (Donnell, 2010). In addition, an 
ecological study in Taiwan also provided evidence of the effect of HAART treatment on 
prevention of HIV (Fang, 2004; Montaner, 2006). Similar results were found in population based 
observational studies in San Francisco (Das, 2010). The study reported a 53% reduction rate in 
the number of new HIV positive test after offering free HAART treatment to all affected by HIV. 
Observational studies from British Columbia also reported a decrease in new HIV infections 
between 1995 and 1998 alongside expansion in HAART access (Montaner, 2006).  
As a result, TasP has gained support from numerous international organisations such as 
the World Health Organization (WHO) and The Joint United Nations Programme on HIV/AIDS 
(UNAIDS). These observations led to the implementation of HIV treatment as prevention in 
British Columbia and paved the way for the inception of the STOP HIV/AIDS project in British 
Columbia. 
STOP HIV/AIDS is a provincial initiative that was originally rolled out in 2010 and 
implemented in two health service delivery areas (HSDA), the Vancouver HSDA and the 
Northern Interior HSDA. The project expands HIV testing, treatment and support services for all 
British Columbians and is deployed through the various provincial health authorities (HA). The 
project was expanded to the rest of the province on November, 30th 2013 by the BC Ministry of 
Health (Heath, 2014). The STOP HIV/AIDS project has been associated with a reduction in 
mortality, morbidity and HIV transmission (Montaner, 2014).   
 STOP HIV/AIDS implementation is supported by the Leadership Committee, which 
includes representation from health authorities, the Provincial Health Services Authority, the BC 
Centre for Excellence in HIV/AIDS, and representatives from the community. Each HA has a 
STOP HIV/AIDS team that implements the project in their respective Health Authorities and is 
overseen by the BC Ministry of Health. HA led teams, although slightly differ, primarily consist of 
epidemiologists, program managers, coordinators, medical health officers and regional 
managers.  
The STOP HIV/AIDS project aims are (MOH, 2012): 
Primary Aims 
Aim 1: To enhance HIV case finding in BC 
Aim 2: To increase the number of HIV-positive people accessing care 
Aim 3: To increase the number of HIV-positive people on HAART, consistent with the 2008 
Therapeutic Guidelines 
Aim 4: To monitor HIV/AIDS related morbidity and mortality and HIV incidence in BC 
Secondary Aims 
Aim 5: To monitor drug adherence, resistance, and adverse events 
Aim 6: To expand health care capacity to support HAART 
Aim 7: To monitor population impact, resource utilization and cost-effectiveness associated with 
expansion of HAART access 
Aim 8: To model the potential impacts of further HAART expansion in BC 
Quarterly reports 
The British Columbia Centre for Excellence in HIV/AIDS (BC-CfE) oversees the 
monitoring of the STOP HIV/AIDS program through province-wide and HA specific quarterly 
monitoring reports. These monitoring reports were developed to address the STOP HIV/AIDS 
goals, based on key indicators constructed through a collaborative process by a representatives 
from all five HA and to help inform future STOP HIV/AIDS planning (Lourenco, 2014). HA Goals 
of the project include: a reduction in the number of new HIV infections in BC; improvements in 
the quality, effectiveness, and reach of HIV prevention services; an increase in early diagnosis 
of HIV; a reduction in AIDS cases and HIV-related mortality (Lourenco, 2014). 
The first STOP HIV/AIDS quarterly monitoring report was issued in the second quarter of 
2013, making them available to end-users for about 3 years now. Quarterly reports provide up-
to-date data on a variety of key HIV-related surveillance and treatment indicators. The report 
comprises of 4 sections that encompass a total of 13 indicators (See table 2). Selection of these 
indicators was achieved through a collaborative process with various Health Authority 
representatives. There are six reports in total, one for each HA and one for the province of BC 
as a whole. In addition, there is a technical report which explains how each HIV indicator is 
constructed (BC-CfE, 2014). Data used in these reports are obtained from several different 
sources. The British Columbia Centre for Disease Control (BCCDC) provides surveillance data 
on HIV, the BC-CfE provides data from the treatment registry and health administrative 
databases are obtained from the Ministry of Health (Nosyk, 2013). Additional data is retrieved 
from the provincial drug dispensation records and mortality records. 
 
 
The objectives of the STOP quarterly monitoring reports are to: 
1. Provide timely HA-specific information on key HIV indicators which will guide and inform HIV 
leaders and innovators in the development of future HIV interventions and programs which will 
ultimately lead to decreasing the burden of HIV in BC. The indicators will reflect ongoing or past 
successful public health interventions and highlight areas in the HIV care spectrum which 
require further attention and support.  
2. Highlight limitations in our current data due to incomplete or time lagged data and to develop 
future strategies to improve complete and timely data capture 
Defining Public Health surveillance systems 
Public Health surveillance systems are a tool used in public health to estimate the health 
status, disease incidence and behaviours of populations (Nsubuga, 2006). The Centre for 
Disease Control in Atlanta defines public health as the ongoing systematic collection, analysis 
and interpretation of data that results in public health action (CDC, 2011). Alexander Langmuir, 
the first chief epidemiologist at the CDC is widely known as the founder of public health 
surveillance. In 1968, Langmuir and colleagues at the World Health Organization conducted the 
very first public health surveillance assembly (Thacker, 2012). This assembly set the foundation 
for public health and epidemiologic surveillance as we know today.  
An important distinction to note about public health surveillance is that they branch off 
into two major types: active surveillance and passive surveillance. HIV infection and AIDS cases 
are typically reported through a combination of active and passive surveillance. Active 
surveillance is a system that employs staff to collect data regularly from health care service 
providers (Nsubuga, 2006). Active surveillance occurs when health departments or 
organisations proactively collect information about diseases. Although expensive and time-
consuming, it provides the most accurate and timely information. An example of active HIV 
surveillance data is data collected through visits by staff members to clinics and hospitals to 
ensure accurate and timely data reporting.  
In contrast, passive surveillance systems compiles notifications of diseases by relying on 
health care providers such as hospitals and clinics to regularly report (Nsubuga, 2006). Passive 
surveillance systems depend on compliance from health care providers and can lead to under-
reporting of diseases. Although, passive surveillance system do not provide as timely or 
accurate information because of its reliance on external institutions to report data - it is cheaper 
to implement. An example of a passive surveillance system would be a surveillance system that 
involves the diagnosing doctor to provide information on date of testing, route of exposure, 
place of infection and the results of HIV tests voluntarily and regularly to health authorities. This 
information provided by the physicians would then be analyzed and included in a surveillance 
system. 
HIV/AIDS surveillance has evolved over the years and has helped shaped our 
understanding and response to the epidemic. AIDS surveillance preceded HIV surveillance and 
initiated in 1981 by the CDC in the United States. For the next decade AIDS surveillance 
changed as the definition of AIDS evolved to include individuals with indicator diseases such as 
Kaposi Sarcoma and Pneumocystis (Valdiserri, 2000). These revisions to the definition of AIDS 
ultimately increased the usefulness of AIDS surveillance, as more cases were being diagnosed 
by physicians (Valdiserri, 2000). AIDS related morbidities and mortalities declined as 
advancement were made in HIV prevention and treatment (Gulick, 1997). Thus, in order to 
capture the effect of these interventions, AIDS surveillance alone was ineffective in the reporting 
of trends in HIV infection (CDC, 1996; Gulick, 1997).  
It was not until 1997 that the CDC in the United States urged all states and territories to 
expand on their AIDS surveillance to include HIV surveillance as well (Gulick, 1997). 
Furthermore, HIV surveillance research done by the CDC found that 25 states reported 
decreases in AIDS incidence but did not find comparable reduces in newly diagnosed HIV 
cases (Valdiserri, 2000). This effectively led to the broader use of HIV surveillance data as a 
prevention tool to create policies, monitor and control the HIV/AIDS epidemic.   
The BC-CfE quarterly monitoring reports comprise of a combination of active and 
passive surveillance systems. Some of the data is passively collected through statistics Canada 
and vital statistics BC whereas, other data such as BC-CfE drug treatment program database is 
actively collected directly by the BC-CfE. 
 
Role of surveillance systems as tools in public health  
Historically, the best recognized uses of public health surveillance data are in the 
detection of disease epidemics and population health problems. Since its growing uptake in 
public health in 1968, surveillance systems have been estimating the magnitude of health 
problems and the geographic and demographic distribution of health issues (Thacker, 2012).  
Public health surveillance systems enable governments and organizations to monitor 
and accurately describe the patterns of disease in a population and provide the data needed to 
guide interventions for populations. In addition, they support program planners in understanding 
the dynamics of epidemics among different populations in different settings (Pervilhac, 2005). 
Surveillance data are also used for advocacy (Pervilhac, 2005) and are crucial for tracking 
progress and informing resource allocation decisions while empowering decision makers to lead 
and manage more effectively (Innes, 1990; Jamison, 2006).  
Evidence based decision-making is increasingly advocated for and used in public health 
(Taylor, 2010). Evidence-based decision-making consists of relevant, up-to date population data 
and evidence derived from scientific studies (Taylor, 2010). To help inform the decision-making 
process data on certain populations and their sub-groups is required, along with the prevalence 
of the problem and potential interventions. Surveillance systems provide the population level 
data and evidence required to guide effective and meaningful decision-making by policy makers 
(Chu, 2012; Taylor, 2010). Thus, surveillance systems have been increasingly used and play a 
pivotal role in assessing initiatives and formulating new strategies in public health.   
Although surveillance systems play a significant role in decision and policy making; a 
number of qualitative and survey-based studies suggest that data from surveillance systems 
may have limited role in informing public health decision-making. A study done evaluating a 
syndromic surveillance system in Ontario found its limited use in decision-making (Chu, 2102). 
Similarly, a study evaluating a national paediatric surveillance system reported that out of 15 
public health professionals surveyed, only 3 reported using the surveillance reports to formulate 
and guide policy decisions (Gazarian, 1999). Likewise, a study done in Australia reported low 
use of reports for strategic planning and decision-making (Pope, 2005). 
Another key role within the decision-making process is the role surveillance systems 
play in the prevention and monitoring of epidemics such as HIV/AIDS. Surveillance systems 
generate data that is required for monitoring and evaluating the impact of specific HIV 
interventions (Larmarange, 2015). In addition, HIV/AIDS effects diverse groups of individuals 
and surveillance helps identify which communities are affected the most, subsequently, tailoring 
treatment and prevention efforts to these communities.  
Significance of performance indicators 
 Performance indicators in surveillance reports also play a pivotal role in 
monitoring and preventing disease incidence. The significance of performance indicators is well 
documented in the literature (Birch, 1986; Brownson, 2009; Freeman, 2002). Indicators provide 
a source of accountability and a source of formative quality improvement (Freeman, 2002). 
Furthermore, they provide visible and concrete proof of performance within a surveillance 
system (Freeman, 2002). The Declaration of Commitment on HIV/AIDS adopted at the UN by 
189 member states in 2001 measured success in AIDS response by the achievement of 
concrete, time bound targets (UNAIDS, 2010), a practice that has continued with the latest 
targets, set out by UNAIDS, to diagnose 90% of those infected, treat 90% of those diagnosed, 
and ensure 90% viral suppression among those treated by 2020 (UNAIDS, 2014). Reaching the 
UN goals entails the careful monitoring of progress in the specific indicators used in HIV/AIDS 
surveillance. Effective HIV/AIDS indicators enables surveillance systems to evaluate the 
effectiveness of their policies and programs.  
Evaluation of surveillance systems 
Ensuring public health surveillance systems are efficient and effective is increasingly 
recognized as critical to improving health conditions across all disease areas. Evaluation of 
surveillance system is a method to ensure that resources are being used effectively and 
ensures issues of public health importance are monitored effectively (CDC, 2001; Drewe, 2012). 
Evaluation of surveillance systems also plays an essential role in maintaining trust and 
credibility from all authorities involved in the project or funding the initiative (Drewe, 2012).  
A surveillance system is considered useful if it generates a public health intervention that 
reduces the negative health effects (CDC, 2001). A report issued by the CDC on guidelines for 
evaluating surveillance systems states that surveillance systems, although uniquely different in 
methodology and objectives, should all be evaluated periodically to promote the best use of 
public health resources (CDC, 2001). Evaluations assess if surveillance systems serve as a 
useful public health tool and more importantly, if they are meeting the systems objectives (CDC, 
2001).  
The literature on evaluations of surveillance systems is divided in two groups: studies 
assessing the usefulness and uptake of reports and studies conducting formal evaluations on 
an array of different attributes of surveillance systems (Calba, 2015; CDC, 2001; Drewe, 2012). 
Assessing the usefulness of surveillance systems is deployed through qualitative and 
quantitative methods, in the form of survey and in-depth of interviews. A study assessing the 
usefulness of STI surveillance data in Australia used a survey to assess the readership and 
uptake of reports while conducting interviews to assess how useful the reports were and how 
they informed policy changes. Similarly, Pega at al. explored the extent and ways in which the 
reports were used by administering surveys and conducting interviews (Pega, 2013). 
The literature showed mixed results on the uptake of surveillance reports among 
intended end-users. Numerous studies found surveillance reports to have low uptake and 
readership while other studies found reports to be used extensively (Grenier, 2004; He, 2009 
Knowles, 2012, Pega, 2013; Pope, 2005). A study evaluating the use of a British Paediatric 
surveillance system and their effect on policy through questionnaires found reports were used 
extensively by UK paediatricians (Knowles, 2012). However, a similar study found that only 49% 
of end-users reported that they used the surveillance reports (Pope, 2005). Similarly, another 
study reported that end-users of surveillance reports found indicators or reports in general to be 
hard to interpret and thus seldom used (Pope, 2005). Despite, conflicting results of report use 
those in positions of authority such as Medical Health Officers and Directors had a tendency to 
use the reports less (Pope, 2005).  
 The literature on the usefulness of reports strongly show that surveillance reports were 
useful and valuable to end-users (Pope, 2005; Grenier, 2004; Knowles, 2012). Studies 
consistently found end-users to be satisfied with the overall content and quality of reports 
(Grenier, 2004; Pope, 2005; Pega, 2013,). However, end-users of the surveillance reports 
stated different reasons as to why they found the report valuable and useful. Grenier et al., 
reported 70% of participants used the report as guide to inform immediate action while 40% 
used the reports as the basis for future research (Grenier, 2004). Other studies reported the 
surveillance reports were used for reference purposes, gaining knowledge on disease trends 
and evaluating public health policy (Grenier, 2004; Pega, 2013).  
Lack of evaluation has been argued to hinder the development of data and surveillance 
systems and prevent maximizing the utility of surveillance reports (Sandiford, 1992). 
Furthermore, regular and relevant evaluations of surveillance systems are crucial to the 
improvement of performance and efficiency. Evaluations of surveillance reports should conclude 
with recommendations for improving quality, efficiency, usability and usefulness (CDC, 2001). 
Above all, evaluations should focus on how well a surveillance system is meeting its own 
objectives.  
Currently, there are different methods of evaluating surveillance system constructed by 
the CDC and WHO that cover many different attributes of surveillance. Evaluations of 
surveillance system based on these aforementioned guidelines do exist and are more 
commonly practised and are predominately tailored towards active surveillance systems. The 
methodology deployed by this study uses many of the attributes recommended by the CDC and 
WHO but differs because our surveillance system is not just an active surveillance systems but 
a combination of both passive and active systems. In addition, our study serves as a preliminary 
exploration of the perceived usefulness and uptake of quarterly monitoring reports among report 
users, with the ultimate goal to identify areas for improvement. The literature on the evaluation 
of surveillance systems is divided into two categories: in-depth evaluations on the specificity, 
simplicity, flexibility, sensitivity and predictive value positive and evaluations that aim to 
determine the usefulness, uptake and role in decision-making of the surveillance reports 
(Banks, 2001; Bingle, 2005; Gazarian,1999; Pega, 2013; Pope, 2005). Studies differ because 
surveillance systems objectives vary and thus emphasizes certain attributes more than others. 
For the purpose of this capstone this paper will prioritise usefulness, simplicity and uptake 
attributes for our evaluation.  
Study Goals 
While the role monitoring and surveillance systems play in improving health outcomes is 
well documented (German, 2001; Innes, 1990; Larmarange, 2015; Segone, 2008), the use of 
STOP HIV/AIDS quarterly reports and more specifically, their impact on policy has not yet been 
evaluated. The study aims to explore and understand the use of quarterly reports by 
representatives of the Health Authorities on the STOP project. The main goal of this study is to 
improve our understanding of the uptake of monitoring reports by Health Authorities and their 
use of indicators to improve the quality of HIV care in British Columbia. In particular, the study 
will investigate the extent to which monitoring reports guide and inform future interventions and 
policy decisions for decision-makers. The findings from this study can determine if 
developments to the monitoring reports and indicators would be valuable.  
Objectives of study 
This study seeks to understand how monitoring reports and their indicators are used by HA end-
users, and their role in informing policy decisions as quality improvement tools. The research 
questions are:   
1. What are the HA-led team members’ perspectives on the usefulness of quarterly monitoring 
reports? For the purposes of this study, usefulness is defined as the extent to which an 
information system provides benefits or value to end-users. 
2. What do Health Authority-led teams understand to be the purpose/goal of the quarterly 
monitoring reports? 
3. What role do the quarterly reports play in policy and programmatic decision-making within the 
Health Authorities? 
4.  What are the Health Authority-led teams’ perspectives on the significance of specific sections 
and indicators to their operations? 
 Which indicators are considered most significant towards quality improvement 
work? 
 Which indicators are difficult to interpret? 
 How could sections and indicators be presented differently to better meet needs 
of health authorities?  
5. How could the quarterly monitoring reports be improved to better meet end-user needs?  
Methodology 
 
Research Design 
 The study was a mixed methods design that employed a survey questionnaire as 
well as in-depth interviews with key informants. This allowed us to both assess the uptake of the 
reports while also gaining an in-depth understanding of perceived usefulness of the reports and 
identifying possible recommendations to enhance the quarterly reports. 
The email administered survey was developed through a collaborative process with 
three other members of the study team, including the director of the STOP HIV/AIDS Program 
at the BC-CfE, a senior health economist who works with STOP HIV/AIDS data, and a 
qualitative health researcher. Some questions on the survey were adapted using the CDC 
Updated Guidelines for Evaluating Public Health Surveillance Systems (German, 2001). The 
survey questionnaire assessed the usefulness and impact of quarterly monitoring reports while 
also examining the intensity of use and uptake of monitoring reports at the various health 
authorities that are involved in the STOP HIV/AIDS project. After a few revisions, the survey 
was limited to a total of 14 questions. Surveys were administered online through Fluid Survey 
and disseminated electronically through email. Two follow up reminder emails were sent to non-
responders.  
The next step was the key-informant interviews that aimed to assess the perceived 
usefulness of the monitoring reports and indicators to HA end-users, and their subsequent 
influence on the decision-making process. The in-depth interview guide was developed through 
a collaborative process with all involved in the study and adapting the questions and formats of 
interview plans recommended in the Guide to Organizing Semi-structured Interviews with Key 
Informants: Safety Diagnosis Tool Kit for Local Communities (Laforest, 2012). After multiple 
revisions and a pre-test of the interview, a semi-structured interview consisting of 6 sections 
was finalized.  
Sampling and Recruitment 
 The study surveyed members from two committees involved on the STOP HIV/AIDS 
project, the Technical Monitoring Committee (TMC) and the Collaborative Implementation 
Committee (CIC). Members were representatives of their respective HA and consisted of 
Medical Health Officers, Epidemiologists, Regional Managers and Directors of Prevention 
Services and Project Coordinators (See table 1). Key-informants from these two committees 
were selected for recruitment from this pool by the Chair of the STOP HIV/AIDS technical 
monitoring committee, who is also the Assistant Director at the BC-CfE and Senior Medical 
Director at Vancouver Coastal Health, along with the Director of Operations at the BC-CfE. Four 
members were selected through snowball sampling by pre-selected participants who were 
either not available or felt their involvement with the quarterly reports were limited. All 
participants that were identified by chair of the STOP HIV/AIDS and director of operations were 
included in the study. Participants were sent initial invitation emails to participate in the study. 
After a week, one follow-up invitation was sent to non-responders. A total of 13 interviews were 
conducted and were all one-on-one interviews except for one that was conducted with two 
participants concurrently.  
Interview Guide 
We chose to conduct in-depth interviews to gain a deep understanding of the use of 
quarterly monitoring reports. The interview guide was established through multiple drafts and 
revisions before being finalized (See Appendix B). Although a survey was also deployed, 
qualitative methods such as interviews are more informative and useful for capturing the 
experiences of participants (Steinar, 1996). Conducting interviews will assist in producing 
reliable and in-depth qualitative data while also allowing for the opportunity to identify new 
questions that may emerge through the use of open-ended questions (Bourgeault, 2010; 
Turner, 2010). Semi-structured interviews will allow us to retain the flexibility of qualitative 
research while also allowing for greater standardization (Bourgeault, 2010). 
 The literature indicates that qualitative methods are highly effective when conducting 
outcome evaluation (Steinar, 1996). Interviews allow participants to discuss their needs and 
thoughts without being restricted to a pre-selected categories. The interview guide comprised 
questions assessing: the usefulness of the reports by end users, end users perceptions of the 
usefulness of the reports, the purpose or role of the quarterly reports, their role in decision-
making and the significance of the various performance indicators.   
The project used quantitative methods in the form of a survey questionnaire 
administered through the web. Surveys allowed us to collect the same set of data from all 
participants and quantify the usefulness of the reports to end-users. Survey questionnaire 
collected similar data as the qualitative interviews however, focused more on the uptake and 
specific questions on the usefulness of the reports (See appendix A).  
Procedure 
Interviews were conducted form July 17th to August 7th, 2015. The majority of the 
interviews were conducted at each health authority the participants were working for, with the 
exception of three individuals who requested to be interviewed at the BC-CfE. All interviews 
were conducted in private rooms. Interviews ranged from 25 to 55 minutes. 
Data Analysis  
Each of the interviews was audio taped and transcribed. Thematic data analysis was 
conducted to analyze the interview data to assess the use and the impact of the reports on the 
STOP HIV/AIDS projects work by the HA’s in the province. Green and Thorogood’s (2009) 
approach and guidelines was applied for thematic analysis. A thematic analysis approach was 
selected due to its usefulness in answering the most salient issues in a research project (Green, 
2004). It emphasizes the examining and pinpointing of data to identify implicit and explicit 
themes found in the data rather than simply counting phrases or words in a text (Green, 2004). 
Interviews were reviewed, coded and analyzed by one researcher. Thematic analyses was 
conducted by reading transcriptions several times, producing initial open codes, generating 
themes by collating codes, reviewing and refining themes and generating the final report. 
Themes were separated into parent themes that matched the original research objective 
inspired themes, and subsequently sub-themes were identified. 
Findings 
 Findings from the survey and qualitative interviews are presented separately in two 
sections.  
Survey Results 
HA-led team members’ perspectives on the usefulness of quarterly monitoring reports  
Survey results indicated that many of the key informants do not review the reports 
regularly. 63% of respondents stated that they ‘always read’ the report, compared to 27% who 
reported they ‘sometimes read’ the reports. When asked how often they read the reports each 
quarter, the majority (45%) stated less than an hour; while 27% responded 1-2 hours and 3-5 
hours, respectively. In addition, 45% of respondents reported that they held meetings to discuss 
the reports once a quarter, while 27% stated that they held meetings ‘less often than quarterly’. 
This could in part be explained by the low scoring of the ‘ease of reading and navigating’ 
through the reports. 54% of respondents scored the ‘easiness of reading navigating’ through the 
reports from 4-7, where 10 is “very easy”.  
Purpose of the Quarterly Monitoring Reports and the role they play in policy and 
decision-making 
When asked how they use the report, 81% responded for planning and implementing 
public health initiatives, another 81% stated they use the reports to evaluate public health 
initiatives. In contrast, only 45% used the reports to inform the development of policy decisions.  
 
Significance of specific indicators  
Overall, the informants were comfortable with the indicators included in the report and 
the quality of the indicators. When asked how well end-users understand the indicators, 63% of 
respondents scaled the results between 8-10, (10= completely understand and 0= do not 
understand). 45% of respondents rated the relevance of indicators to their work between 8-10, 
where 10 is “very relevant”. When asked if end-users of the reports have ever asked for and 
needed clarification of the data in the report, 63% responded “no”.  
Finally, when respondents were asked what their preferred format to access the report, 
54% of respondents indicated they would prefer to change the format while 36% stated that they 
preferred to keep the current format. Of the respondents that preferred a new format, 45% 
selected an interactive web-based tool. 
 
Qualitative Results  
 
HA-led team members’ perspectives on the usefulness of quarterly monitoring reports 
and purpose of the Quarterly Monitoring Reports to users 
Comparability of reports 
Producing HA specific reports every quarter was described as very beneficial to each 
HA. All participants stated that they preferred HA specific reports over just having a province 
wide report, as it allowed them to compare their progress to other HAs. One interviewee 
indicated that they “…see [the reports] as a way for them to look at how all the health authorities 
are doing in relation to the mandate we have been given from the ministry”. 
In addition, interviewees stated that having the ability to compare results also allowed 
them to see where certain HA are doing well. This in turn would lead to adopting policy or 
interventions that worked for certain HA and implement them at their respective HA. As one 
participant stated, 
“…to have a graph of figures that have all of the health authorities on there and shows 
side by side or maybe even the same graph so that you can say “oh my god look at Island 
health and the wonderful job they are doing and getting people who are more active on therapy. 
We can then contact them and ask what they are doing and how are you doing it and then we 
can share methodology and intervention.” Interviewee 2 - Epidemiologist 
Reports as a way to “help reach goals”   
 Many participants, when asked how the quarterly monitoring reports aided in their work 
towards reaching the STOP goals, indicated that it allowed them to assess their progress 
towards the goals every quarter. Interview participants stated that the quarterly reports enables 
them to see how their activities or the STOP program in general are positively effecting the 
HIV/AIDS status in their regions. One participant stated,  
“The purpose is to help people reflect on the impacts of their activities and adjust 
those activities in a way that is data informed and try to constantly do better to 
meet the targets of the program”. Interviewee 4 – STOP coordinator 
Interviewees acknowledged that without the report it would be difficult to evaluate their 
work. As one client stated, “We definitely are using it to evaluate, we are keeping our eyes very 
closely on the numbers and as we roll programs and as we change programs we do look at 
these reports to see if there are any differences in the numbers we are seeing”. 
Furthermore, many participants specified that the reports allow them to provide updates 
on testing rates and HIV/AIDS incidence rates to their HA, media and community organizations. 
One participant stated that they used the reports “to share updates on our progress of testing 
and treatment and engagement in care”.  
Quarterly Monitoring Reports role in policy and decision-making 
Emerging role of reports in decision-making 
One of the main objectives of this study was to understand how the reports informed 
policy decisions. All participants noted that the quarterly reports informed their decision-making 
process. However, many participants could not give specific examples of how quarterly reports 
had informed specific policy or programmatic decisions. One participant stated, “We are still in 
the active roll out of the STOP HIV, we are definitely not at the sitting back and waiting back for 
the fruits to be sowed. We are still trying to plan and roll out…”. Some participants stated that 
the reports helped them target priority populations that were identified in the report. Many 
participants said they constantly used the reports to evaluate their progress. However, 
participants did acknowledge the benefit of using the reports for strategic planning in the future. 
The significance of specific indicators  
Some indicators difficult to interpret 
Overall, most participants liked the majority of indicators and found them to be very 
helpful to their work. Interviewees described using the testing indicators the most, followed by 
the new HIV diagnoses indicator, the stage of HIV infection and the cascade of care. 
Participants also stated they were comfortable interpreting the indicators. However, some 
participants found some of the indicators either difficult to interpret or not helpful towards their 
work. Almost all participants stated the indicators they found to be not helpful or that they did not 
refer to quarterly were the HIV mortality and AIDS defining illness solely due to the very small 
numbers of deaths; instead they viewed these indicators on an annual basis. Many participants 
said they did not use the PCS score indicator because they found it hard to interpret. Of the 
interviewees that used the PCS score, only one participant, a clinician, indicated that they used 
it often.  
Cascade of Care metrics may not be capturing adherence sufficiently 
The cascade of care was another indicator that received mixed views from participants. 
The majority of interviewees used the cascade of care and referred to it often, stating it enabled 
them to see the number of individuals not linked to care and ultimately virologically supressed. 
However, a few participants stated that the definitions of the cascades needed to be explained 
better in order to fully understand each stage of the cascade of care. In particular, some 
participants did not agree with the adherence definition and felt that the definition should be 
changed to individuals who are fully adherent to treatment and not individuals who only pick up 
medications, as they may not be fully adherent. They stated they had issues with the drop off 
between number of individuals who were adherent and individuals suppressed. As one 
participant stated,  
“…we have plenty of discussion about the definitions of the measures for adherence. 
Because I think it’s defined as people who pick up their medications on a regular basis. Which 
doesn’t necessarily mean they are taking it. So, and we often see that it is relatively high in 
adherence but the suppression levels are low and it really should be almost the same if we were 
really measuring adherence well.” Interviewee 5 – Medical Health Officer 
Current stratification is sufficient 
When asked about the stratifications of the indicators, participants all stated that further 
stratifications were not needed and the current stratifications of gender, age, and exposure 
category were sufficient. Many participants stated that if any further stratifications were needed 
that each HA would take it upon themselves to create them. 
 
Areas for improvement 
The themes compiled in this section describe the limitations and barriers of the quarterly 
monitoring reports. Participants identified limitations that reduced the uptake of the reports that 
could be improved upon. In this section, I will explain the limitations and the suggestions 
participants offered to improve the reports. Finally, I will conclude with additional areas of 
improvement that could increase the uptake and utility of the reports 
More accessible format of the report 
Although participants appreciated that the data was compiled for them by the BC-CfE 
and saved them a lot of time, a number of participants identified the format of the report as a 
barrier that limited use of the reports. The quarterly reports are currently in the form of a PDF 
document that is sent to all STOP members and is accessible online on the STOP website as 
well. Participants noted that the PDF format does not allow them to extract certain data, graphs 
or tables that were significant to their work. One participant stated, “We have never been able to 
get that data in terms of a usable file where you can actually extract information. They have only 
ever sent us it as a PDF”.  
Although, some participants stated they were still able to extract the data they needed 
but could only do so through tedious methods such as cropping and pasting. It was noted by 
one of participants as: “A pdf you have to download and then take a snapshot and then cut and 
paste. But often when you go to expand it, it’s not as clear. So yes, it is a problem but not all the 
time”. Extracting data through this method was possible but was an inconvenience that could be 
addressed.  
Participants suggested to change the format of the report to a more accessible and 
extractable form such as an excel file. Excel files would enable participants to extract the data 
they need faster and with better quality.  
Reports are quite lengthy 
Many participants identified the overall length of the reports as a barrier as well. 
Participants stated that they would only look for the data they needed and either briefly skim the 
report and/or ignore all other sections of the report. They stated the impediments to reading 
through the report in its entirety was mainly due to its length. As one participant noted,  
“…what they [members of the STOP project] won’t do is go through a 25 page [quarterly 
report] and extract the information that they need from it and then kind of sort through what 
variables and what tables and figures are appropriate”. Interviewee 3 - Epidemiologist 
Another participant echoed these comments and said, “The one thing about it is every 
quarter you have to go through it [quarterly report] and you have to look at every section”. 
Despite, the concern with the length of report participants did not advocate to reduce the report 
or omit any of the indicators. They acknowledged the importance of all indicators but did not like 
the length of reports.   
Succinct high level summary would be helpful 
As a suggestion to increasing the uptake of the reports, participants stated they would 
like to receive a succinct high level summary with key highlights sent alongside the quarterly 
reports. By providing this summary page with the quarterly reports, end users would not miss 
any significant information. One participants described what the summary page would consist of 
as: “…it doesn’t have to be long, it doesn’t have to be several pages just a one pager with high 
level summary that kind of tell you what’s happening”.  
Another participant noted, “What they need is a targeted one pager that goes out to 
them that they can hold that says testing rates by LHA and then some draft that shows them the 
testing rates for LHA. They could just quickly look and then move on”. 
Additional data 
A contradiction arose between the length of the report and the inclusion of more data. 
Participants previously noted that the length of the report was a barrier that reduced the utility of 
the report. However, the same participants also indicated they would support adding more data 
into the reports. The themes below that supported the addition of new data include the 
granularity of data, inclusion of harm reduction and STBBI data and knowledge translation.  
Granularity of data 
Most clients interviewed stated that BC-CfE could add more granular data – local health 
area (LHA) - as opposed to just health service delivery areas. Participants from the Health 
Authorities that covered larger geographical areas were the most vocal about adding LHA level 
data. They found that HSDA level data were too broad to use. One participant noted that 
although LHA level would be nice they felt it was the responsibility of the health authority to 
break down data into more granular data.  
Inclusion of harm reduction data 
End-users of the report indicated that they would also like to see harm reduction data 
and Sexually Transmitted and Blood-borne Infection (STBBI) data incorporated into the 
quarterly reports. Participants indicated that incorporating harm reduction data such as needle 
and condom distribution would be helpful in identifying patterns and trends in HIV diagnoses. As 
two participants stated: 
“The harm reduction side is such a key part of HIV prevention and should maybe 
go on the reports.” Interviewee3 - Epidemiologist 
“there isn’t any data spit out around harm reduction work. I don’t know if that will 
change anytime soon. That’s something that could be all integrated into one 
report” Interviewee 7 – Medical Health Officer 
Although the epidemiologist advocated the most for the inclusion of harm reduction data 
and STBBI data, at least two other end-users that were interviewed shared this view as well.   
More knowledge translation needed 
Another area that was identified by participants that could improve the use of the 
quarterly reports was adding more knowledge translation – interpretation and breakdown of 
indicators. Although brief descriptions of each indicator and graph are provided in the reports, 
participants indicated that some of the graphs and indicators were difficult to interpret and 
suggested more knowledge translation of indicators. Participants felt that more knowledge 
translation would improve their understanding of the reports and subsequently, increase the 
uptake of the reports. One participants described the need for more knowledge translation as: 
“I think what’s missing between the monitoring reports versus what’s in the hope 
to health is some of those context pieces. What does this mean or what is past 
just the pure stats and what’s is happening and what does that mean in that 
context or what you are doing.” Interviewee 4 – STOP HIV/AIDS coordinator 
Another participant acknowledged the technical reports but stated having some explanations 
accompanying the indicators would be helpful for most end-users, as some might not know the 
technical reports exist. Some participants that wanted more knowledge translation were 
advocating for front-line workers who might use the reports. One participant noted that by 
having more knowledge translation attached to the indicators, the uptake of the reports would 
increase amongst frontline workers.  
Although these explanations are also suggested to be included in the succinct high level 
summary, participants did not want a breakdown of every indicator in the summary but only the 
key indicators and significant changes to be included in the summary piece.  
  
Discussion 
 The results from the study showed that end-users from the HA’s used the quarterly reports 
for evaluating progress, attaining provincial goals and comparing across HA. Reports were not 
disseminated actively nor were meetings held frequently within HA to discuss results from the 
quarterly reports. Respondents also reported that the quarterly reports enabled them to assess 
the progress of the project and towards reducing HIV/AIDS burden. The indicators in the reports 
were found useful and valuable to work done by the HA-led STOP teams with the exception of a 
few respondents that felt like they were difficult to interpret, use, or not significant to their work. 
Overall, the study showed that the quarterly monitoring reports could be improved by providing: 
succinct one or two page documents highlighting key changes; changing the format of the report 
to a more accessible format; including more granular data and simplification of data for frontline 
staff.  
Although our results are encouraging, they indicate areas of possible improvement to 
increase the uptake of reports. Our findings show that the participants could not describe 
specific applications of the quarterly monitoring reports for strategic planning and decision-
making, despite participants responding in the survey that reports were used for planning public 
health initiatives. Although they did not report using the reports for policy making, participants 
did acknowledge the perceived role the reports would play. These results were consistent with 
those found in the literature (Banks, 2001; Pega, 2013; Pope, 2005). A study conducted in the 
US found a quarter of policy makers didn’t examine state surveillance systems despite 
recognizing the usefulness of the surveillance reports (Pope, 2005). Similar studies reported 
end-users seldom use of the reports to inform strategic planning and decision-making (Pega, 
2013).   
Our study found various different usages for the quarterly monitoring reports. Participants 
stated the reports were useful in measuring progress, reaching goals, reducing HIV/AIDS 
burden and assessing trends in HIV/AIDS. The uses of the reports were consistent with the 
literature (Banks, 2001; Bingle, 2005; Pega, 2013; Pope, 2005). Studies reported using the 
reports mainly for accessing information and trends (Banks, 2001; Pega, 2013). 
Another interesting usage of the reports that is not found in the literature is how participants 
used the reports to compare how their respective HA was doing in relation to the other HA’s. 
Furthermore, some participants noted they might use the reports information to adopt policies or 
interventions from HA’s who are doing significantly well in certain areas of the STOP project. 
This was notable because ‘comparability’ was not one of the objectives of the quarterly 
monitoring reports. Also, this may have negative implications given the difference amongst HA 
in size and target populations, making it difficult to draw any valuable findings through 
comparisons of the aggregate data alone.  
Survey results from our study found that 45% of respondents read the report for ‘less 
than an hour’ and 27% said they spend ‘1-2 hours’ per quarter reading the report. Although our 
core focus was not to capture the readership of the reports, these number gave us a glimpse 
into the uptake of the reports among a diverse group of end-users. The findings of the 
qualitative interviews suggest that report uptake and use could be limited by the format and 
length of the report. The quarterly monitoring reports are quite long, and consist of 36 pages 
with 16 figures and 14 tables, and a total of 13 performance indicators. The length of reports 
were also identified as barriers to readership and uptake of reports in the literature (Banks, 
2001; Pope, 2005). Participants stated reports uptake would increase if a summary page was 
attached to it. A similar study done in Australia also found end-users who found the reports to 
be dense and cumbersome advocated for a summary article (Pope, 2005). Including a high 
level summary page could increase the uptake and understanding of the reports.  
Additional indicators 
Participants were comfortable with most of the indicators and did not face many 
difficulties interpreting the data in the indicators with the exception of a few. There were a 
couple indicators that participants identified as not being a significant to their work. Participants 
suggested providing more definitions and explanations for some of the indicators such as the 
cascade of care and the programmatic compliance score. Overall, the indicators were identified 
as significant to the work of the health authorities.  
Participants did also suggest including more indicators. Mainly, the inclusion and 
integration of other sexual transmitted infections (STI), hepatitis and other blood borne 
diseases. Literature on integrated surveillance systems show that integrating behavioural, 
hepatitis and STI data with HIV surveillance is critical to understanding the biological and 
behavioural dynamics and could also serve as a proxy measure to the effectiveness of HIV 
prevention programmes (Defraye, 2011; Rehle, 2004; Mills, 2004). In the late 1990’s, UNAIDS 
and the WHO introduced second generation surveillance to supplement HIV surveillance. 
Second generation surveillance includes assessing behavioural and STI data trends to further 
understand which behavioural changes are responsible for HIV as well as blood borne 
infections (Zaba, 2005). PLWHA are not only susceptible to HIV but can also face threats from 
other disease. MSM and IDU communities can also face higher risk of STI and hepatitis due to 
similar transmission routes (Dowell, 2009). Furthermore, co-infection of HIV and STBBI has 
been shown to alter treatment recommendation due to changes in the clinical course of disease 
(Dowell, 2009; Rehle, 2004). Studies advocating for the integration of HIV, STBBI and 
Tuberculosis base this on the mounting epidemiological and biological evidence that have 
pinpointed the cofactor role STI’s play in facilitating HIV transmission (Rehle, 2004). A study that 
integrated surveillance systems reported that HIV care providers were alerted to a rise in HIV 
and syphilis co-infection which led to more interventions to prevent transmission (Dowell, 2009). 
However, challenges and barriers do exist and include incompatible databases, time lag on 
reporting of STBBI/HIV data and the length of time to integrate and lack of expertise (Dowell, 
2009). Harmonizing HIV and STBBI surveillance enables policy makers to implement effective 
prevention strategies and only strengthen and improve existing surveillance system (Dowell, 
2009; Sweeney, 2013) 
Respondents also asked for the addition of harm reduction’s data such as condom and 
needle use and distribution and other safe injection supplies in the monitoring reports. Harm 
reduction’s role in reducing the HIV epidemic is well documented (Ball, 2007; Zambrana, 2003). 
Harm reduction data enables decision-makers to create policies and interventions that can 
target drug users specifically and further strengthen the existing programs (Zambrana, 2003). 
Current harm reduction data is compiled by the BCCDC Communicable Disease Prevention and 
Control Services by Health Authority. The literature on advocating for the integration of harm 
reduction data as it applies to HIV surveillance is sparse. However, given the evidence of 
effectiveness for harm reduction data, including harm reduction data could increase the 
effectiveness of surveillance data and help account for social and cultural factors that affect HIV 
transmission. 
Respondents also felt that the inclusion of granular data would help assist in identifying 
target areas within their respective HA regions. The literature shows that the inclusion of small 
area geographic data can improve surveillance systems by better locating epidemics, targeting 
populations needs and provide insights into the service use of rural populations (Pope, 2005). 
Furthermore, it would improve the understanding of trends and provide insights into the patterns 
of more rural areas (Pope, 2005). However, providing more granular data poses an ethical issue 
because it could easily identify PLWHA. A study done in Australia reported that granular data 
could be produced while also making it difficult to disaggregate the data through methods such 
as standardization and combining several years of data (Pope, 2005). 
Desired format for reports  
The format of the report was also identified to be a barrier in uptake of the reports. The 
PDF format of the report makes it difficult to extract data or graphs directly form the report. 
Participants often use the data and graphs from the report to include in their presentations or 
disseminate within their respective HA or affiliated community organizations. Participants also 
noted that an easier format to navigate through reports would be helpful. Participants reported 
that an interactive web-based tool that allows them to compare outcomes over time more easily 
would help identify effective interventions. The literature on the use of interactive web-based 
tools is scarce. However, the UN data development group found that disseminating data 
through more user-friendly platforms ensures greater use and understanding of the reports 
(UNICEF, 2010). Customized interactive web based surveillance reports would enable end-
users to compare trends, extract and manipulate data with greater ease.    
When analyzing the data on length of the report a contradiction arose between asking 
for more detail and brevity. Almost all respondents reported the reports were too long. Despite 
finding the report lengthy, some respondents also stated they would like more data to be 
included into the report. The data requested included: more granular data, linking STBBI data 
and harm reduction data, and more descriptions on the construction of some of the indicators. 
This paradox in the length of data begs the question if there is an issue with the way the reports 
are communicated to end-users. An interactive web-based tool could include the additional data 
end-users requested while also providing a different format that does not make the report seem 
as lengthy or cumbersome. 
Research Limitations  
The study had a few limitations and possible biases that could have altered the results of 
the study. Due to the nature of the study and timing (summer) there were a smaller number of 
participants and thus results are less generalizable. The study sample was small but was 
appropriate given the small size of our target population of HA end-users. Also, our study 
included member of the HA’s with various different titles, with both senior and junior level 
members - representing a wide variety of users. We chose not to target frontline workers due to 
their limited engagement with the reports and because we were targeting HA members who 
were in a position to influence decision-making. 
Response bias in the form of overstatement bias may have also been present in the 
study. Key informants may have given more positive feedback due to the fact the interviewer 
was representing the BC-CfE - the centre responsible for compiling and sharing the quarterly 
reports. An external interviewer may have received different feedback. For example, participants 
may have had lower uptake of reports in practice, but may have given better answers to present 
themselves in a more favourable light. Therefore, it is possible that respondents over-estimated 
their uptake and use of the reports in our study because of moderator presence bias – 
respondents interpreting what they believe the interviewer wants to hear.  
In addition, purposive sampling might have reduced the representativeness of the 
participants and subsequently, affected the results from this study. Participants in the study 
were not randomly selected but were selected through purposive sampling and snow-ball 
sampling techniques. Furthermore, of the initial group of participants identified, it is likely that 
individuals who responded and volunteered to be in the study might have had more 
engagement with the quarterly monitoring reports. Thus, our results could have had different 
findings from members who might not have volunteered to be in the study due to their limited 
engagement in the report.  
Another limitation was some of the participants selected for the study were only on the 
STOP HIV/AIDS project for a short time, the shortest length of time being 7 months and the 
longest since the projects inception. Participants who were on STOP initiative for a short time 
may not have been able to provide detailed information on how the reports have guided and 
informed decision-making.   
We would also like to acknlowdged that PLWHA, although at high-risk could also be part 
of a community that is underserved or marginalized. PLWHA are already subject to the stigmas 
and discrimination brought about by their illness, however, if they are already from a 
marginalized community this stigma is only further perpetuated and exacerbated. Our study did 
not focus on the community or patient level and thus, did not have a health equity approach. 
However, this could have limited the inclusiveness of the surveillance reports and its ability to 
capture these nuances amongst communities.  
Future Research 
This study illuminated many uses and benefits of the report as well as areas for 
improvement. Future research is needed to evaluating different attributes that are critical in 
improving surveillance systems. WHO and CDC recommend evaluating attributes such as 
timeliness, specificity, reliability, acceptability, sensitivity, predictive value positive, 
representativeness and stability of surveillance systems (German, 2001). Delving into these 
attributes could reveal more about the impact of the performance indicators, their quality and 
efficiency.  
Studies focusing on the readership of the report might also prove valuable. This would 
provide quantified data on the use and readership that could explain why reports might not be 
used for strategic planning. Also, it could provide insight into how different end users might 
engage with the reports and if being a senior member and junior member might affect the use of 
reports.   
Future research could also evaluate the impact and significance of applying a health 
equity lens to the surveillance report. Possibly adding some indicators that would provide a 
more holistic data collection that is representative of all populations affected by HIV/AIDS. 
Surveillance of equity related health outcomes and social determinants of health is highly 
significant (Marmot et al, 2008) and would inform programs and policies that would ultimately 
improve the HIV/AIDS care in BC.  
Future studies could also include more participants in both the survey and the in-depth 
interviews, while also expanding participants to include front-line workers and community 
NGO’s. Additionally, interviewing more STOP HIV/AIDS program managers and coordinators 
from each health authority may reveal more information.  
Conclusion 
The study has shown how there is a need for some improvements to the quarterly 
reports. The current reports are used for various different purposes such as guiding policy 
making and evaluating progress as reported by key-informants. The length of the reports 
coupled with the current format of the report are major factors in the uptake of these reports. 
Providing succinct summaries of the reports and changing the format could improve the uptake 
of the reports and their role in informing decision-making. Further work evaluating the different 
attributes along with the readership and adopting the WHO guidelines on the evaluation of 
surveillance data could provide valuable information on the efficiency and quality of reports; 
subsequently, providing additional novel ways of increasing uptake and the impact of the 
quarterly monitoring reports. 
Critical Reflection  
           The study allowed me to gain invaluable experience conducting research and working 
with a renowned HIV/AIDS research centre, but it also provided me with many lessons learned. 
It gave me the opportunity to apply both qualitative and quantitative research methods which 
were highly beneficial. Constant collaboration and guidance from my preceptors helped 
enhanced the rigour of the methodology of the study. However, as my first study there are many 
areas that I could improve on that would have increased the rigour and efficiency of the study. 
Although I improved my interviewing skills throughout the course of the study, I think I could 
have still improved on probing interviewees when themes emerged that were outside of the 
research objectives. This did negatively affect my ability to analyze, understand and report on 
these emerging themes. Similarly, interviewees who gave shorter, less detailed answers for 
some question or were less open to discussing certain questions could have been improved by 
more consistent probing.  
                One lesson I leant is that it would have been helpful to be more reflective while 
conducting the qualitative interviews and thematic analysis. Possible biases on my end could 
have been identified through better note keeping throughout the data collection and data 
analysis stages. My literature review skills were also significantly improved as a result of this 
study. I was able see the significance of continuously re-visiting the literature and how this could 
have better informed my research protocol. Lastly, I have gained a thorough understanding of 
the many steps and processes involved in conducting research from inception to completion 
Overall, I developed many essential research skills while also gaining invaluable experience of 
the research process that I can build on in the future.  
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Appendices 
Appendix A – Survey Questions 
Thank you for agreeing to participate in this survey measuring the use of monitoring reports as 
well as the usefulness of the reports to your organization. Given your involvement in the STOP 
HIV/AIDS/Hope to Health project we would like to ask you the following questions about the 
quarterly monitoring reports and how you use them. 
The quarterly monitoring reports were introduced two years ago to evaluate the project and 
identify future interventions. Obtaining feedback from everyone involved on the project is vital to 
improving the reports, and ultimately the quality of care for people living with HIV/AIDS across 
the province.  
The survey should take no more than 10 minutes to complete. Your responses are voluntary 
and will be kept confidential; analyses will use summarized, de-identified data.  
1. What is your role/position on the STOP HIV/AIDS project? 
2. How familiar are you with the goals of the STOP HIV/AIDS (Hope to Health) project? 
 Very Familiar 
 Somewhat Familiar 
 Not familiar  
3. How often do you consult and review the quarterly monitoring report each quarter? 
 Always Read 
 Sometimes 
 Never Read 
4. What do you use the reports for? 
 For planning or implementing public health initiatives 
 To inform the development of policy  
 To evaluate public health practices 
 Other (Please Specify) 
5. How many hours do you spend reading and working with the new quarterly monitoring report 
every quarter? 
 Less than 1 
 1-2 
 3-5 
 More than 5 hours 
6. Do you hold a regular meeting to discuss the results of the quarterly monitoring reports as a 
team? 
 Yes 
 No 
7. How often do you hold a meeting to discuss the results? 
 Less than bi-weekly 
 Bi-weekly 
 Monthly 
 Quarterly 
 Other (Please specify)  
8. On a scale of 1-10 with 10 being “very useful”, how useful are quarterly monitoring reports to 
your organization?  
 Not useful -1 ------ Very useful - 10 
 
9. On a scale of 1-10 with 10 being “very useful”, how would you rate the quarterly monitoring 
reports usefulness as a quality improvement tool? 
 Not useful -1 ---- Very useful - 10 
10. On a scale from 1-10, with 10 being “very relevant”, how would you rate the relevance of the 
indicators to your work? 
11. Do you think the quarterly monitoring report is missing any information that would be 
valuable to you? 
 Yes 
 No 
12. If so, what do you think is missing? 
13. On a scale of 1-10 with 10 being “very easy” how would you rate the ease of reading and 
navigating through the quarterly monitoring reports? 
 
Very hard – 1 ----- Very easy - 10 
14. On a scale of 1-10 with 10 being "completely understand", how would you rate your 
understanding of what the indicators are measuring? 
 
 Don’t understand at all – 1 ----- Understand very well- 10  
15. Have you ever asked for clarification or additional data to be included in the quarterly 
monitoring report? 
 Yes 
 No 
16. If so, was this clarification useful, in that it sufficiently answered your question to the extent 
that you were able to carry out your intended task pertaining to the data? 
 Yes 
 No 
17. What would be your preferred format to access the report? 
 Hard copy mailed to you 
 Downloadable Report from the website 
 Interactive web based tool to customize indicators 
 Other (please specify) 
  
 
 
 
 
 
 
 
 
 
Appendix B - Semi- Structured Interview Guide: 
***You were identified and selected to participate in this study because of your involvement in 
the STOP HIV/AIDS project. We feel like you would have extensive and detailed knowledge on 
the project, more specifically, the quarterly monitoring reports. The questions I will be asking 
today will mainly focus on the use of monitoring reports and the role they play in informing 
strategic planning.*** 
Interview Questions 
A - Intro – Profile of individual responding  
 To begin, could you tell me a little bit about your role at the [Health Authority/} 
 How would you describe your role in relation to the STOP/HIV AIDS project? 
 How long have you been working in your current position? 
 What was your role at the HA before you began working on the STOP project?  
 What other ongoing projects at the HA are you involved in? 
 How much of your time would you say that you spend working on STOP? 
B - HA perceptions of STOP HIV/AIDS project goals 
 How would you describe the goals of the STOP HIV/AIDS project? 
 How would you describe your success in achieving these goals to date? 
 How would you measure success in relation to this project? 
o Why? 
*** In this next section I will ask a couple questions pertaining to the use of the monitoring 
reports. As you know monitoring reports are used as a quality improvement and evaluation tool 
and are overseen by the BC-CfE. The reports are issued every 4 months about six weeks after 
the end of each quarter. We would like to explore and understand how the reports are used, the 
process in place to review the reports and how useful they are to the STOP HIV/AIDS team. As 
such, I’d like to ask some questions next about the use of monitoring reports. *** 
C - The Use of Monitoring Reports by HA 
 What would you describe as the purpose of the quarterly monitoring reports? 
 What happens when the new quarterly report comes out?  
 Within your team, what sort of process is in place within to review the monitoring 
report use as a team? 
o Has this process changed over time?  
o If so, in what way? 
 Within your team, what sort of process is in place within to respond to the 
monitoring report use as a team? 
o Has this process changed over time?  
o If so, in what way? 
 Could you tell me a little bit more about who is responsible for reviewing 
quarterly reports within your health authority? 
o How often are reports reviewed as a team within the quarter? 
 How are quarterly reports disseminated and circulated within your health 
authority? 
o How, if at all, are they disseminated beyond your HA? 
*** Monitoring reports play a vital role in informing policy making processes. Strong evidence 
originating from monitoring reports can lead to informing the decision and choice of policy, 
forecasting the future and evaluating policy impact. In this section I will ask question regarding 
the role monitoring reports play in informing strategic planning for the STOP HIV/AIDS 
project.*** 
 
D - Role of Monitoring Reports in Informing Policy Decisions  
 Could you tell me a little bit more about how quarterly reports have been used to 
inform planning and assessment? 
o If they haven’t, what do you perceive would be the role the reports would 
play in informing decisions?  
 To what extent do quarterly reports help support the progression towards STOP 
HIV/AIDS project goals? 
 I understand there was a short period after the STOP HA teams were created 
before the Quarterly Reports were introduced. Can you tell me a little bit more 
about the decision-making process around TasP implementation at that time? 
o How has it changed since then? 
*** So we’ve talked broadly about the way that you interact with the Reports and how it 
influences your decision-making.  We’re very interested to learn more about your perspective on 
the specific indicators and to what extent you feel they are sufficient in meeting your needs. I’ve 
brought a copy of the latest STOP Quarterly Monitoring Report with me here. As you know, 
there are 13 indicators in the report, outlining various HIV-specific indicators. Each section 
stratifies the overall indicator by gender, age group and exposure category. These indicators are 
intended to help guide and inform development of future interventions and programs. As such, 
I’d like to ask some questions next about your overall understanding of the performance 
indicators and their significance to your Health Authority *** 
E - The overall understanding of the HA led teams of the performance indicators 
 What section of the report is most significant to your priorities at [health authority] 
right now? 
o Is there a specific indicator within this section that you pay more attention 
to? 
o [Is the indicator stratified?] What is your perspective on the value of the 
stratification? 
o What (if any) other stratification would you like to see? 
 What section of the report is least significant to your priorities at [health authority] 
right now? 
o Is there a specific indicator within this section that you feel is particularly 
problematic? 
o [Is the indicator stratified?] What is your perspective on the value of the 
stratification? 
o What, if anything, do you think would make this indicator more useful to 
your decision-making process? 
 Which indicators do you think are difficult to understand? 
o What aspect of the indicator is most confusing?  
 [presentation/construction/thematic focus] 
 
 
F - How can Monitoring Reports be improved? 
 How could the STOP HIV/AIDS monitoring report be improved to increase its use 
and its impact on strategic planning and decision-making? 
o Focus and content of report on the whole? 
o Section? 
o Indicators? 
o Strata? 
 
Closing Question 
 Are there any other thoughts about the construction and use of the Quarterly 
Monitoring Reports that you wanted to share? 
*** That’s the end of the interview. Thank you for your time*** 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Appendix C – Breakdown of participants: 
 
Table 1 – Breakdown of 
interview participants 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2 – Breakdown of indicators in quarterly monitoring reports 
INDICATORS  DATA SOURCE  
Role  Affiliation 
Epidemiologist Fraser Health   
Medical Health Officer Fraser Health 
Epidemiologist Island Health 
Medical Health Officer Island Health 
STOP & STBBI Manager Island Health 
Regional Director for 
Prevention 
Vancouver Coastal Health 
Epidemiologist Interior Health 
STOP Coordinator Interior Health 
Regional Manager of HIV & 
HEP C 
Northern Health 
Regional Navigator for HIV 
and HEP C 
Northern Health 
Physician Provinvial Health Services 
Authority 
Evaluation Manager Pacific AIDS Network 
INDICATOR 1. HIV TESTING 
EPISODES 
The number of HIV test episodes 
and point of care (POC) HIV tests 
conducted each quarter in BC 
BC-CDC 
INDICATOR 2. HIV TESTING RATE  BC-CDC 
INDICATOR 3. NEW HIV 
DIAGNOSES 
Trends in HIV diagnoses by gender 
and exposure category are 
described 
BC-CDC 
INDICATOR 4. STAGE OF HIV 
INFECTION AT DIAGNOSIS 
Classification of stage of HIV 
infection 
BC-CDC 
INDICATOR 5. HIV CASCADE OF 
CARE 
The Cascade of Care provides a 
picture as to where deficiencies lie 
in the delivery and uptake of HIV-
care 
BC-CfE; BC Vital Statistics 
database; British Columbia Ministry 
of Health 
INDICATOR 6. PROGRAMMATIC 
COMPLIANCE SCORE (PCS) 
The Programmatic Compliance 
Score (PCS) is a summary measure 
of risk of future death, immunologic 
failure and virologic failure from all 
causes for people who are starting 
ART for the first time 
BC-CfE 
INDICATOR 7. NEW 
ANTIRETROVIRAL THERAPY 
STARTS 
The number and proportion of new 
HIV treatment initiations and the 
number of active and inactive DTP 
participants 
BC-CfE 
INDICATOR 8. CD4 CELL COUNT 
AT ART INITIATION 
CD4 Cell Count at ART Initiation of 
ART-Naïve DTP Participants in BC 
BC-CfE 
INDICATOR 9. ACTIVE AND 
INACTIVE DRUG TREATMENT 
PROGRAM (DTP) PARTICIPANTS 
Distribution of People on ART for 
BC and Active and Inactive DTP 
Participants 
BC-CfE 
INDICATOR 10. 
ANTIRETROVIRAL ADHERENCE 
Trends in prescription refill 
adherence levels for individuals in 
BC-CfE 
their first year of treatment are 
shown 
INDICATOR 11. RESISTANCE 
TESTING AND RESULTS 
Present trends in cumulative 
resistance testing by different 
resistance category 
BC-CfE 
INDICATOR 12. AIDS-DEFINING 
ILLNESS 
AIDS cases per quarter BC-CfE 
INDICATOR 13. HIV-RELATED 
MORTALITY 
HIV-related deaths BC-CfE; BC Vital Statistics 
database; Statistics Canada 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix D - Survey Results 
1. How often do you consult or review the quarterly monitoring reports? 
Always Read 63% 
Sometimes Read 27% 
Never 9% 
 
 
2. How often does your organization hold meetings to discuss the results of the quarterly 
monitoring reports? 
Quarterly 45% 
Monthly 9% 
Less often than quarterly 27% 
More often than Bi-weekly  9% 
Never 9% 
27
63
9
How often do you consult and review the 
quarterly monitoring reports
Always Read Sometimes Read No Response
 3. How many hours do you spend reading and working with the quarterly monitoring 
reports every quarter? 
Less than an hour 45% 
1-2 hours 27% 
3-5 hours 27% 
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quarterly
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discuss the results of the quarterly monitoring 
reports?
45%
27%
27%
How many hours do you spend reading 
and working with the quarterly 
monitoring reports every quarter?
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4. On a scale of 1-10 with 10 being “very useful”, how useful are quarterly monitoring 
reports to your organization? 
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On a scale of 1-10 with 10 being “very useful”, how 
useful are quarterly monitoring reports to your 
organization?
